Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.

Microbial drug resistance (Larchmont, N.Y.) - 1 Dec 2009

Doustdar Farahnoosh, Khosravi Azar Dokht, Farnia Parissa

Abstract excerpt

Pyrazinamide (PZA) is an important first-line drug used for the short-course treatment of tuberculosis in combination with isoniazid and rifampin. It has been reported that mutations in pncA gene correlate well with PZA resistance depending on the geographic area. On the other hand, different genotypes of Mycobacterium tuberculosis show different affinities to acquire resistance-related mutations. To determine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases
Share to Antitubercular Agents
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Mycobacterium tuberculosis

Share to Pyrazinamide

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 19857130
DOI: 10.1089/mdr.2009.0066

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.PMID 19857130Read ↗

Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.Semantic proximity Read ↗

Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany.Semantic proximity Read ↗

Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.Semantic proximity Read ↗

Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.Semantic proximity Read ↗

Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, ChinaSemantic proximity Read ↗

Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.Semantic proximity Read ↗

Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.Semantic proximity Read ↗

Characteristics of pncA mutations in multidrug-resistant tuberculosis in TaiwanSemantic proximity Read ↗

Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.Semantic proximity Read ↗

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium TuberculosisSemantic proximity Read ↗

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.Semantic proximity Read ↗

Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.